Vaccination may combat Clostridium difficile

UK - Whilst the life-threatening Clostridium difficile is not absolutely resistant to antibiotics, after an individual has been infected the bacteria often reappears.

Photo: Vaccination may combat Clostridium difficile

Vaccination against it is therefore seen as the possible answer, and now results from initial trials of one made by Acambis, a Cambridge-based biotech company, have encouraged its scientists to discuss involvement of the National Health Service (NHS) in tests in hospitals this year.
Rather than targeting the infection, this developing vaccine focuses on the toxins produced by a C. difficile infection. Trials on 200 patients indicate that the vaccine was effective at combating one of the major toxins in 100% of cases and a second major toxin in 75% of cases.
It is hoped that a course of three injections will provide long-lasting protection for over a decade.

01.03.2008

More on the subject:
Read all latest stories

Related articles

Photo

Sponsored • Gastrointestinal endoscopy

Innovating products that balance patient safety and environmental concerns

As transparency surrounding the eco-footprint of hospitals becomes more important, medical device manufacturers must recognize the need for action to tackle global challenges, such as climate change.

Photo

News • Hard to break down

Hepatitis E: Most common hand infectants no match for HEV

Scientists have investigated the effectiveness of various common hand disinfectants against hepatitis E. They were able to show that most formulations do not completely inactivate the virus.

Photo

Sponsored • Reprocessing equipment

A breakthrough technology for endoscope drying and storage

Due to their complex design, reusable endoscopes have been long recognized to require thorough reprocessing to properly disinfect. In practice, the drying of the endoscope is often underestimated.

Related products

Mesalvo – LabCentre

LIS, Middleware, POCT

Mesalvo – LabCentre

Mesalvo Mannheim GmbH (ehemals i-SOLUTIONS Health GmbH)
Subscribe to Newsletter